HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilles Cambonie Selected Research

Viral Bronchiolitis

1/2021Assessment of Peak Inspiratory Flow in Young Infants with Acute Viral Bronchiolitis: Physiological Basis for Initial Flow Setting in Patients Supported with High-Flow Nasal Cannula.
1/2019High-flow nasal cannula flow rate in young infants with severe viral bronchiolitis: the question is still open.
11/2018A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).
7/2017High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows.
2/2017High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study).
1/2014High-flow nasal cannula: recommendations for daily practice in pediatrics.
6/2013Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study.
1/20136 cmH2O continuous positive airway pressure versus conventional oxygen therapy in severe viral bronchiolitis: a randomized trial.
10/2008Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilles Cambonie Research Topics

Disease

9Viral Bronchiolitis
01/2021 - 10/2008
5Infections
06/2022 - 01/2004
5Bronchiolitis
02/2020 - 03/2006
3Hemorrhage
12/2021 - 04/2007
3Asthma (Bronchial Asthma)
01/2021 - 01/2014
2Shock
12/2021 - 12/2016
2Pulmonary Hypertension
12/2021 - 01/2018
2Patent Ductus Arteriosus
01/2021 - 01/2020
2Cerebral Palsy (Spastic Diplegia)
01/2021 - 01/2016
2Dystonia (Limb Dystonia)
12/2020 - 01/2018
2Birth Weight (Birth Weights)
05/2012 - 06/2004
2Hypothyroidism
11/2010 - 04/2009
2Hypertension (High Blood Pressure)
03/2007 - 06/2004
1Multiple Organ Failure (MODS)
12/2021
1Parkinsonian Disorders (Parkinsonism)
12/2020
1Dysphonia (Spastic Dysphonia)
12/2020
1Menkes Kinky Hair Syndrome (Menkes Disease)
01/2020
1Pain (Aches)
01/2020
1Pneumonia (Pneumonitis)
04/2019
1Hyperkinesis
01/2018
1Cardiogenic Shock
12/2016
1Methylmalonic acidemia
08/2016
1Hyperhomocysteinemia
08/2016
1Weight Gain
01/2016
1Weight Loss (Weight Reduction)
01/2016
1Dysbiosis
10/2015
1Dysentery
10/2015
1Vocal Cord Paralysis
06/2015
1Sepsis (Septicemia)
08/2014
1Inflammation (Inflammations)
01/2014
1Hyperandrogenism
07/2013
1Primary Ovarian Insufficiency
07/2013
1Laminopathies
07/2013
1Werner Syndrome (Werner's Syndrome)
07/2013
1Insulin Resistance
07/2013
1Lipodystrophy
07/2013
1Necrotizing Pneumonia
01/2013
1Cross Infection (Nosocomial Infection)
08/2012
1Hypotension (Low Blood Pressure)
05/2012
1Neutropenia
06/2011
1Cholestasis
04/2009
1Goiter
04/2009
1Fetal Growth Retardation (Intrauterine Growth Retardation)
04/2009
1Lung Diseases (Lung Disease)
02/2008

Drug/Important Bio-Agent (IBA)

3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2021 - 03/2007
3Biological ProductsIBA
12/2021 - 07/2013
3Proteins (Proteins, Gene)FDA Link
12/2020 - 06/2004
3helioxIBA
09/2015 - 03/2006
2Oxygen (Dioxygen)IBA
01/2021 - 01/2013
2AntioxidantsIBA
06/2013 - 03/2007
1AnticoagulantsIBA
06/2022
1Ibuprofen (Motrin)FDA LinkGeneric
01/2021
1Ceruloplasmin (Ferroxidase)IBA
01/2020
1CopperIBA
01/2020
1beta-Lactamases (beta-Lactamase)IBA
04/2019
1Methylmalonyl-CoA MutaseIBA
08/2016
1Methylmalonic AcidIBA
08/2016
1RacivirIBA
01/2016
1AcidsIBA
10/2015
1Hemolysin Proteins (Hemolysins)IBA
10/2015
1CoagulaseIBA
03/2014
1LipopolysaccharidesIBA
01/2014
1Tiagabine (Gabitril)FDA Link
01/2014
1Metformin (Glucophage)FDA LinkGeneric
07/2013
1Follicle Stimulating Hormone (Follitropin)FDA Link
07/2013
1DNA HelicasesIBA
07/2013
1Insulin (Novolin)FDA Link
07/2013
1LaminsIBA
07/2013
1Glucose (Dextrose)FDA LinkGeneric
07/2013
1Neuroprotective AgentsIBA
06/2013
1Panton-Valentine leukocidinIBA
01/2013
1Midazolam (Versed)FDA LinkGeneric
08/2012
1CatecholaminesIBA
05/2012
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2012
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2011
1Immunoglobulin G (IgG)IBA
06/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2011
1AntibodiesIBA
06/2011
1AntigensIBA
06/2011
1PropylthiouracilFDA Link
11/2010
1IodineIBA
04/2009
1SodiumIBA
04/2009
1Disinfectants (Biocides)IBA
04/2009
1Contrast MediaIBA
04/2009
1Betamethasone (Celestone)FDA Link
02/2008
1Surface-Active Agents (Surfactants)IBA
04/2007

Therapy/Procedure

6Cannula
01/2021 - 06/2013
6Therapeutics
01/2021 - 04/2010
3Deep Brain Stimulation
12/2020 - 01/2018
3Continuous Positive Airway Pressure
02/2017 - 10/2008
3Critical Care (Surgical Intensive Care)
12/2016 - 01/2007
2Length of Stay
02/2020 - 08/2012
2Enteral Nutrition (Feeding, Tube)
01/2020 - 04/2009
2Respiratory Therapy (Therapy, Respiratory)
09/2015 - 04/2010
1Peritoneal Dialysis
12/2021
1Artificial Respiration (Mechanical Ventilation)
01/2020
1Tracheostomy
06/2015
1Central Venous Catheters
08/2014
1Enema (Enemas)
04/2009
1Intravenous Administration
04/2009